We’ll keep investing in research until we find the cures.
Research is one of our best weapons against breast cancer. Over the past 30 years, it’s fueled our knowledge of breast cancer and helped us understand that breast cancer is not just a single disease but many diseases, unique to each individual. Thanks to supporters like you, we’ve been able to provide more than $889M to researchers in 49 states and 20 countries. And with your help, we’ll keep doing so. Because nothing would make us happier than ending breast cancer forever.
A minimum of 25 percent of the net income from each domestic Affiliate supports the Susan G. Komen Grant Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific conferences around the world.
Your research dollars have helped support more than:
- 2400 research grants in 49 states and 20 countries
- 460 clinical trials
- 300 research advocates
- 60 partnerships and collaborations
- 60 scientific conferences
Learn more about your research dollars at work here.
People right here in the Great Plains are contributing to research in important ways. New board member Emily Poeschl, Director of Marketing at UNO, was recently named a Susan G. Komen® Advocate in Science. The Advocates in Science program (AIS) is a community of dedicated volunteer advocates who work to reduce the burden of breast cancer in their communities. Research advocates bring the patient voice to research, ensuring that the unique and valuable perspectives of breast cancer patients, survivors, and co-survivors are integrated into the scientific dialogue and decisions, which impact progress toward ending breast cancer. Click here to learn more.
Dr. Kristi Egland is working in South Dakota to eradicate breast cancer. With the help of a Susan G. Komen Career Catalyst Research award, Dr. Egland established her own laboratory to test her ideas. She had two primary goals – to identify new ways to treat breast cancer and to develop a simple blood test that could detect breast cancer at an early stage. These research goals became even more of a driving force when she was diagnosed in 2007 with invasive Triple Negative Breast Cancer that had spread to her lymph nodes.
Today, Dr. Egland is focused more than ever on her research goals and is making progress toward creating a blood test to detect cancer.
Hear more about her journey here.